A
Abhinav Kumar
Researcher at King's College London
Publications - 17
Citations - 475
Abhinav Kumar is an academic researcher from King's College London. The author has contributed to research in topics: Darunavir & Drug delivery. The author has an hindex of 11, co-authored 16 publications receiving 373 citations. Previous affiliations of Abhinav Kumar include University of Cambridge.
Papers
More filters
Journal ArticleDOI
Long-term stability, biocompatibility and oral delivery potential of risperidone-loaded solid lipid nanoparticles.
TL;DR: The RISP-loaded SLN systems were stable and had high EE and similar shape to the placebo formulations before and after storage, and the viability of SLN as formulations for oral delivery of poorly water-soluble drugs such as RISP was illustrated.
Journal ArticleDOI
The delivered dose: Applying particokinetics to in vitro investigations of nanoparticle internalization by macrophages.
Raha Ahmad Khanbeigi,Abhinav Kumar,Fethi Sadouki,Chris Lorenz,Ben Forbes,Lea Ann Dailey,Lea Ann Dailey,Helen L. Collins +7 more
TL;DR: This study demonstrates that dose correction using the ISDD model is essential for accurate interpretation of results derived from in vitro particle-cell interaction studies (e.g. particle uptake, cytotoxicity, mechanisms of action, pharmacodynamic studies, etc.).
Journal ArticleDOI
Enrichment of immunoregulatory proteins in the biomolecular corona of nanoparticles within human respiratory tract lining fluid
Abhinav Kumar,Elif Melis Bicer,Anna Babin Morgan,Paul E Pfeffer,Marco P. Monopoli,Kenneth A. Dawson,Jonny Eriksson,Katarina Edwards,Steven Lynham,Matthew Arno,Annelie F. Behndig,Anders Blomberg,Graham Somers,Dave Hassall,Lea Ann Dailey,Ben Forbes,Ian Mudway +16 more
TL;DR: Functional protein classification supports the hypothesis that corona formation in RTLF constitutes opsonisation, preparing particles for phagocytosis and clearance from the lungs, and highlights how an understanding of the evolved corona is necessary for the design of inhaled nanomedicines with acceptable safety and tailored clearance profiles.
Journal ArticleDOI
A Biocompatible Synthetic Lung Fluid Based on Human Respiratory Tract Lining Fluid Composition.
Abhinav Kumar,Wachirun Terakosolphan,Mireille Hassoun,Kalliopi-Kelli A. Vandera,Astrid Novicky,Richard D. Harvey,Richard D. Harvey,Paul G. Royall,Elif Melis Bicer,Jonny Eriksson,Katarina Edwards,Dirk Valkenborg,Dirk Valkenborg,Inge Nelissen,Dave Hassall,Ian Mudway,Ben Forbes +16 more
TL;DR: The SLF reported herein constitutes a biorelevant synthetic simulant which is suitable to studyBiopharmaceutical properties of inhalation medicines such as those being proposed for an inhaled biopharmaceutics classification system.
Journal ArticleDOI
Brake dust exposure exacerbates inflammation and transiently compromises phagocytosis in macrophages.
Liza Selley,Linda C. Schuster,Linda C. Schuster,Helene Marbach,Theresa Forsthuber,Ben Forbes,Timothy W. Gant,Timothy W. Gant,Thomas Sandström,Nuria Camiña,Toby J. Athersuch,Ian Mudway,Abhinav Kumar +12 more
TL;DR: At minimally cytotoxic doses both DEP and BAD perturbed bacterial clearance and promoted inflammatory responses in U937 cells with similar potency, which emphasise the requirement to consider contributions of abrasion particles to traffic-related clinical health effects.